文献速递脑血管病外科

血管内载瘤动脉闭塞与血流导向装置治疗大型和巨大动脉瘤的随机比较

Endovascular Parent Vessel Occlusion Versus Flow Diversion in the Treatment of Large and Giant Aneurysms: A Randomized Comparison.
PubMed 文献 · World Neurosurg · 2024-02-26

该研究为FIAT试验的预设治疗亚组分析,纳入45例大型或巨大动脉瘤患者(平均22 mm),随机分配至血流导向装置组22例或载瘤动脉闭塞组23例。主要复合终点不良结局在血流导向装置组为11/22(50.0%),载瘤动脉闭塞组为9/23(39.1%),差异无统计学意义(RR 1.28,95%CI 0.66-2.47,P=0.466)。作者认为两种治疗的比较无定论,需要更多随机试验。

要点

  • 在45例适合载瘤动脉闭塞的大型或巨大动脉瘤患者中,血流导向装置与载瘤动脉闭塞的主要复合终点无显著差异。
  • 主要终点不良结局:血流导向装置组11/22(50.0%),载瘤动脉闭塞组9/23(39.1%),RR 1.28(95%CI 0.66-2.47,P=0.466)。
  • 1年mRS>2的并发症:血流导向装置组4/22,载瘤动脉闭塞组6/23;血管造影结果和严重不良事件相似。

核心结论

  • 载瘤动脉闭塞与血流导向装置治疗大型或巨大动脉瘤的比较无定论,需要更多随机试验来确定血流导向装置在适合载瘤动脉闭塞的大型动脉瘤中的作用。

研究设计与样本

  • 该研究为FIAT试验的预设治疗亚组分析;FIAT为研究者发起的平行组、全纳入、实用性随机试验,在3个中心于2011年至2020年间随机分配278例患者,本报告纳入其中45例(16.2%)以载瘤动脉闭塞作为血流导向装置最佳替代治疗的患者。
  • 45例患者中22例随机分配至血流导向装置组,23例随机分配至载瘤动脉闭塞组;主要分析为意向性治疗分析,无盲法。
  • 主要终点为核心实验室判定的3-12个月血管造影闭塞或近闭塞与独立临床结局(mRS<3)的复合终点。

主要发现

  • 动脉瘤主要为大型或巨大(平均22 mm)前循环(主要为颈动脉)动脉瘤。
  • 主要终点不良结局:血流导向装置组11/22(50.0%) vs 载瘤动脉闭塞组9/23(39.1%),RR 1.28(95%CI 0.66-2.47,P=0.466)。
  • 1年mRS>2的并发症:血流导向装置组4/22 vs 载瘤动脉闭塞组6/23。
  • 血管造影结果和严重不良事件两组相似。

局限性

  • 原文结论指出载瘤动脉闭塞与血流导向装置的比较无定论,需要更多随机试验来确定血流导向装置在适合载瘤动脉闭塞的大型动脉瘤中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Parent vessel occlusion (PVO) is a time-honored treatment for unclippable or uncoilable intracranial aneurysms. Flow diversion (FD) is a recent endovascular alternative that can occlude the aneurysm and spare the parent blood vessel. Our aim was to compare outcomes of FD with endovascular PVO. METHODS: This is a prespecified treatment subgroup analysis of the Flow diversion in Intracranial Aneurysms trial (FIAT). FIAT was an investigator-led parallel-group all-inclusive pragmatic randomized trial. For each patient, clinicians had to prespecify an alternative management option to FD before stratified randomization. We report all patients for whom PVO was selected as the best alternative treatment to FD. The primary outcome was a composite of core-lab determined angiographic occlusion or near-occlusion at 3-12 months combined with an independent clinical outcome (mRS<3). Primary analyses were intent-to-treat. There was no blinding. RESULTS: There were 45 patients (16.2% of the 278 FIAT patients randomized between 2011 and 2020 in 3 centers): 22 were randomly allocated to FD and 23 to PVO. Aneurysms were mainly large or giant (mean 22 mm) anterior circulation (mainly carotid) aneurysms. A poor primary outcome was reached in 11/22 FD (50.0%) compared to 9/23 PVO patients (39.1%) (RR: 1.28, 95% CI [0.66-2.47]; P = 0.466). Morbidity (mRS >2) at 1 year occurred in 4/22 FD and 6/23 PVO patients. Angiographic results and serious adverse events were similar. CONCLUSIONS: The comparison between PVO and FD was inconclusive. More randomized trials are needed to better determine the role of FD in large aneurysms eligible for PVO.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Boisseau W, Darsaut TE, Fahed R, et al. Endovascular Parent Vessel Occlusion Versus Flow Diversion in the Treatment of Large and Giant Aneurysms: A Randomized Comparison. World Neurosurg. 2024. PMID: 38417622. doi:10.1016/j.wneu.2024.02.114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。